{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-276139","form_type":"8-K/A","ticker":"BHC","cik":"0000885590","company_name":"Bausch Health Companies Inc.","filed_at":"2023-11-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.254128+00:00","generated_at":"2026-06-08T05:56:59.726469+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Bausch Health's B+L closes $1.75B acquisition of XIIDRA from Novartis; issues $1.9B in debt","bullets":["Bausch + Lomb acquired XIIDRA and other ophthalmology assets from Novartis for $1.75B upfront cash plus up to $750M in milestone payments.","To finance the acquisition, B+L incurred $1.9B debt: $1.4B 8.375% Senior Secured Notes due 2028 and $500M term B loans.","Pro forma total assets increase to $27.4B; long-term debt rises to $22.0B; equity decreases slightly.","Acquired assets historical net assets $1.72B; pro forma adjustments include $125M intangibles reduction and $23M goodwill.","Bridge Facility of $1.75B canceled upon closing; $1.9B debt issuance replaces it."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-276139","json":"https://secwatch.observer/filing/0001193125-23-276139.json","markdown":"https://secwatch.observer/filing/0001193125-23-276139.md","text":"https://secwatch.observer/filing/0001193125-23-276139.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/885590/000119312523276139/0001193125-23-276139-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/885590/000119312523276139/d295308d8ka.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T05:56:59.726469+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}